A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 8, 1997, Pages 853-859

  Olsen, O T ^a,c   Larsen, K R ^a   Jacobsen, L ^b   Svendsen, U G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ALK ABELLÓ   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Allergy; Asthma; House dust mites; Immunotherapy; Treatment

Indexed keywords

ALUTARD; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; STEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; MALE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0030805826     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb02157.x     Document Type: Article

References (17)

1. Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma - a worldwide problem. J Allergy Clin Immunol 1989;83:416-27.
2. Korsgaard J. Mite asthma and residency - a case control study on the impact of exposure to house dust mites in dwellings. Am Rev Respir Dis 1983;128:231-5.
3. Svendsen UG, Olsen OT, Petersen LN, editors. House dust mites and allergy. Position papers, Danish Society for Allergology. Allergy 1991;46 Suppl 11.
4. Olsen OT, Jacobsen L, Svendsen UG. Effectiveness of benzyl benzoate in elimination of house dust mites. Aerobiologia 1996;12:3-8.
5. Olsen OT, Frølund L, Heinig JH, Jacobsen L, Svendsen UG. A double-blind randomized study investigating the efficacy and specificity of immunotherapy with Artemisia vulgaris or Phleum pratense/Betula verrucosa. Allergol Immunopathol (Madr) 1995;23:73-8.
6. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.
7. Haugaard L, Mosbech H, Heinig JH, Østergaard PA. Treatment of patients allergic to house dust mites. Allergy 1991;46 Suppl 11:26-32.
8. Mosbech H, Dreborg S, Frølund L, et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by challenges with allergen and histamine. Allergy 1989;44:499-509.
9. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized partially purified extract of house dust mite, clinical efficacy and side effects. J Allergy Clin Immunol 1993;91:709-22.
10. Aas K, Backman A, Belin L, Weeke B. Standardization of allergen extracts with appropriate methods. Allergy 1978; 33:130-7.
11. ECCS. Standardization of lung function tests. Bull Eur Physiopathol Respir 1983;19 Suppl 5.
12. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
13. Djurup R, Mailing H-J, Sondergaard I, Weeke B. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimes of venom immunotherapy. J Allergy Clin Immunol 1985;76: 46-55.
14. Mailing H-J, Weeke B. Position Paper. Immunotherapy. Allergy 1993;48 Suppl 14.
15. Bousquet J, Calvayrac P, Guérin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-44.
16. van Bever HP, Stewens WJ. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). Eur Respir J 1992;5: 318-22.
17. Pauli G, Bessot JC, Bigot H, et al. Clinical and immunologic evaluation of tyrosine-absorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial. J Allergy Clin Immunol 1984;74:524-35.